Safety and feasibility of nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma.

被引：3
作者：
Singla, Nirmish [1 ]
Elias, Roy [1 ]
Ghandour, Rashed [1 ]
Freifeld, Yuval N. [1 ]
Bowman, Alex Isaac [1 ]
Woldu, Solomon L. [1 ]
Gahan, Jeffrey [1 ]
Bagrodia, Aditya [1 ]
Brugarolas, James [1 ]
Hammers, Hans J. [1 ]
Margulis, Vitaly [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
619
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nephrectomy after response to immune checkpoint inhibitors for metastatic renal cell carcinoma (mRCC): A surgical challenge allowing favorable oncological outcomes.
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Gaillard, Victor
    Lang, Herve
    Balssa, Loic
    Geoffrois, Lionnel
    Albiges, Laurence
    Bensalah, Karim
    Schlurmann, Friederike
    Ladoire, Sylvain
    Bigot, Pierre
    Ingels, Alexandre
    Roubaud, Guilhem
    Cassuto, Ophelie
    Parier, Bastien
    Bernhard, Jean-Christophe
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Barthelemy, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] Nephrectomy after complete response to immune checkpoint inhibitors for Metastatic Renal Cell Carcinoma (mRCC): A surgical challenge allowing favorable oncological outcomes
    Pignot, G.
    Thiery-Vuillemin, A.
    Walz, J.
    Lang, H.
    Balssa, L.
    Geoffrois, L.
    Leblanc, L.
    Albiges, L.
    Bensalah, K.
    Ladoire, S.
    Bigot, P.
    Ingels, A.
    Saldana, C.
    Roubaud, G.
    Piechaud, T.
    Cassuto, O.
    Klifa, D.
    Parier, B.
    Bernhard, J. C.
    Malouf, G.
    Gravis, G.
    Barthelemy, P.
    EUROPEAN UROLOGY, 2021, 79 : S892 - S893
  • [33] CYTOREDUCTIVE NEPHRECTOMY IS ASSOCIATED WITH IMPROVED SURVIVAL FOR SARCOMATOID METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED BEFORE OR AFTER SURGERY WITH IMMUNE CHECKPOINT INHIBITORS
    Paz, Lotan
    Jose, A. Karam
    Viraj, A. Master
    Philippe, E. Spiess
    Charles, C. Peyton
    Sarah, P. Psutka
    Jay, D. Raman
    Chiara, Mercinelli
    Edouard, Nicalse
    Nicholas, D. Robertson
    Barry, Sirard R.
    Amber, Jani
    Manley, Wade J.
    Brandon, Manley
    Dattatraya, Patil
    Glenn, O. Allen
    Surena, F. Matin
    Jason, Abel E.
    Daniel, D. Shapiro
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [34] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    DRUGS, 2018, 78 (14) : 1443 - 1457
  • [35] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Ronan Flippot
    Bernard Escudier
    Laurence Albiges
    Drugs, 2018, 78 : 1443 - 1457
  • [36] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [37] Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
    Bailey, Alexandra
    McDermott, David F.
    CANCER JOURNAL, 2013, 19 (04) : 348 - 352
  • [38] Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
    Abou Alaiwi, Sarah
    Xie, Wanling
    Nassar, Amin H.
    Dudani, Shaan
    Martini, Dylan
    Bakouny, Ziad
    Steinharter, John A.
    Nuzzo, Pier Vitale
    Flippot, Ronan
    Martinez-Chanza, Nieves
    Wei, Xiao
    McGregor, Bradley A.
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Bilen, Mehmet A.
    Choueiri, Toni K.
    Harshman, Lauren C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [39] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [40] Liver injury by immune checkpoint inhibitors in patients with hepatocellular carcinoma.
    Personeni, Nicola
    Pressiani, Tiziana
    Capogreco, Antonio
    Dal Buono, Arianna
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Smiroldo, Valeria
    Bozzarelli, Silvia
    Giordano, Laura
    Aghemo, Alessio
    Santoro, Armando
    Rimassa, Lorenza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345